These may be infectious diseases, cobalamin C defects, mutations in the gene encoding diacylglycerol kinase ε (DGKE), genes of complement system factors, antibodies to complement factor H, organ and tissue transplantation, tumor, autoimmune diseases, etc. The etiology of HUS lay down the basis of its classification. This evidence concerns the gene CFH and hemolytic-uremic syndrome.